序号 |
标题 |
次数 |
作者 |
发布时间 |
84151 |
3-(氨基硝基胍基)-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(ANPTz) |
90 |
WYQ |
2024-11-27 |
84152 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz)离子盐 |
104 |
WYQ |
2024-11-27 |
84153 |
DOTA mono-NHS ester,170908-81-3 羟基琥珀酰亚胺-四氮杂环十二烷四乙酸 |
135 |
zyl |
2024-11-27 |
84154 |
NTR激活MRI造影剂Gd-DOTA-PNB |
124 |
kx |
2024-11-27 |
84155 |
环糊精/聚丙烯酸/聚乙二醇三元复合物 β-CD/PAA/PEG |
93 |
h |
2024-11-27 |
84156 |
6-(5-氨基-1H-四唑)-1,2,4,5-四嗪-3-酮钾盐(K2·TATzO) |
88 |
WYQ |
2024-11-27 |
84157 |
6-(5-氨基-1H-四唑)-1,2,4,5-四嗪-3-酮(TATzO) |
114 |
WYQ |
2024-11-27 |
84158 |
DOTA-Octreotide;放射性示踪剂;大环配体多肽 |
85 |
zcy |
2024-11-27 |
84159 |
Gd-DOTA-E-[c(RGDf K)]2 , Gd-DOTA修饰靶向双环肽E-[c(R GDf K)]2 |
98 |
kx |
2024-11-27 |
84160 |
环糊精基梳状多聚轮烷(CD-PR) |
97 |
h |
2024-11-27 |
84161 |
DOTA Ala Ala COOH DOTA-AA-OH DOTA-丙氨酸-丙氨酸-羧酸 |
91 |
zyl |
2024-11-27 |
84162 |
DOTA-E「c(RGDfK)2」,双环肽螯合物 |
94 |
zcy |
2024-11-27 |
84163 |
peptide-DOTA-Eu ,炔基化的peptide和叠氮化的Eu络合物 |
150 |
kx |
2024-11-27 |
84164 |
环糊精基梳状多聚轮烷(CD-PR) |
130 |
h |
2024-11-27 |
84165 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2;肽类配体 |
100 |
zcy |
2024-11-27 |
84166 |
亚甲基蓝/β-环糊精/聚乙酰苯胺复合物 β-CD/MB/AMD |
161 |
h |
2024-11-27 |
84167 |
DUPAaFFC-AMF-DOTA-Nd ,8-氨基辛酸-苯丙氨酸-苯丙氨酸-半胱氨酸-AMF-DOTA-Nd |
72 |
kx |
2024-11-27 |
84168 |
β-环糊精改性酰胺型聚羧酸减水剂 β-CD-MPC |
104 |
h |
2024-11-27 |
84169 |
DOTA-fCYwKTCT-CHO,204318-14-9 |
95 |
zcy |
2024-11-27 |
84170 |
聚多巴胺改性柠檬酸偶联β-环糊精-纳米银 CD-CA/PDA-xAg |
166 |
h |
2024-11-27 |
84171 |
DOTA-NKL , DOTA偶联肽D-K6L9修饰NGR |
94 |
kx |
2024-11-27 |
84172 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-胺 |
116 |
WYQ |
2024-11-27 |
84173 |
聚苯胺-β-环糊精包合物 PANI-β-CD |
128 |
h |
2024-11-27 |
84174 |
3-氨基-6-(3,5-二甲基吡唑)-1,2,4-三唑并[4,3-b][1,2,4,5]四嗪 |
127 |
WYQ |
2024-11-27 |
84175 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二4-氨基-1,2,4-三唑盐 |
142 |
WYQ |
2024-11-27 |
84176 |
聚六亚甲基单胍接枝β-环糊精 PHMG-β-CD |
112 |
h |
2024-11-27 |
84177 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二1,2,4-三唑盐 |
131 |
WYQ |
2024-11-27 |
84178 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二羟胺盐 |
158 |
WYQ |
2024-11-27 |
84179 |
四嗪吡啶类配合物{[Cu(3-bptz)0.5(L-asp)]·1.5H2O}n(6) |
106 |
WYQ |
2024-11-27 |
84180 |
DOTA标记的c(RGDfK)环肽,DOTA-cyclo(RGDfK) |
107 |
zcy |
2024-11-27 |
84181 |
聚乙二醇-聚乳酸共聚物 MPEG-PLA4armPEG-PLA |
84 |
h |
2024-11-27 |
84182 |
四嗪吡啶类配合物{[Co(4-bptz)(btc)]·2H2O·DMF}n(5) |
144 |
WYQ |
2024-11-27 |
84183 |
四嗪吡啶类配合物{[Mn(4-bptz)(Hbtc)]·H2O·2DMF}n(4) |
72 |
WYQ |
2024-11-27 |
84184 |
DOTA-Ala-Ala-Tyr-COOH,DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
85 |
zcy |
2024-11-27 |
84185 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二肼盐 |
110 |
WYQ |
2024-11-27 |
84186 |
DOTA-TMTP1 ,TMTP1偶联双功能螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
110 |
kx |
2024-11-27 |
84187 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二铵盐 |
107 |
WYQ |
2024-11-27 |
84188 |
DOTA-TATE acetate,DOTA-3-酪氨酰基-奥曲肽醋酸盐 |
77 |
zcy |
2024-11-27 |
84189 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二钠盐 |
139 |
WYQ |
2024-11-27 |
84190 |
p-NCS-Bz-DOTA-GA ,CAS:2125661-64-3 |
90 |
zyl |
2024-11-27 |
84191 |
荧光素FAM标记小分子多肽cNGQGEQc-L , FAM-cNGQGEQc-L , FAM-cNGQGEQc-C |
532 |
kx |
2024-11-27 |
84192 |
DOTA-Gd-Biotin |
84 |
zyl |
2024-11-27 |
84193 |
树枝状大孔二氧化硅纳米粒子(DLMSNs) |
110 |
kx |
2024-11-27 |
84194 |
3,6-二氨基-1,2,4,5-四嗪(DAT) |
183 |
WYQ |
2024-11-27 |
84195 |
环状肽909024-55-1,DOTA-cyclo(RGDfK) acetate |
116 |
zyl |
2024-11-27 |